Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.

Simithy J, Fuanta NR, Alturki M, Hobrath JV, Wahba AE, Pina I, Rath J, Hamann MT, DeRuiter J, Goodwin DC, Calderón AI.

Biochemistry. 2018 Aug 14;57(32):4923-4933. doi: 10.1021/acs.biochem.8b00231. Epub 2018 Jul 31.

PMID:
30063132
2.

Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.

Simithy J, Fuanta NR, Hobrath JV, Kochanowska-Karamyan A, Hamann MT, Goodwin DC, Calderón AI.

Biochim Biophys Acta. 2018 May - Jun;1866(5-6):731-739. doi: 10.1016/j.bbapap.2018.04.007. Epub 2018 Apr 12.

PMID:
29654976
3.

Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase.

Pandey S, Chatterjee A, Jaiswal S, Kumar S, Ramachandran R, Srivastava KK.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):721-6. doi: 10.1016/j.bbrc.2016.08.014. Epub 2016 Aug 4.

PMID:
27498028
4.

Studies on the production of shikimic acid using the aroK knockout strain of Bacillus megaterium.

Ghosh S, Mohan U, Banerjee UC.

World J Microbiol Biotechnol. 2016 Aug;32(8):127. doi: 10.1007/s11274-016-2092-6. Epub 2016 Jun 23.

PMID:
27339308
5.

Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.

Mehra R, Rajput VS, Gupta M, Chib R, Kumar A, Wazir P, Khan IA, Nargotra A.

J Chem Inf Model. 2016 May 23;56(5):930-40. doi: 10.1021/acs.jcim.6b00056. Epub 2016 May 13.

PMID:
27149193
6.

Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.

Krishnasamy SK, Namasivayam V, Mathew S, Eakambaram RS, Ibrahim IA, Natarajan A, Palaniappan S.

Arch Pharm (Weinheim). 2016 May;349(5):383-97. doi: 10.1002/ardp.201600019.

PMID:
27135906
7.

Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.

Rajput VS, Mehra R, Kumar S, Nargotra A, Singh PP, Khan IA.

Appl Microbiol Biotechnol. 2016 Jun;100(12):5415-26. doi: 10.1007/s00253-015-7268-8. Epub 2016 Feb 18.

PMID:
26887318
8.

Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.

Simithy J, Reeve N, Hobrath JV, Reynolds RC, Calderón AI.

Tuberculosis (Edinb). 2014 Mar;94(2):152-8. doi: 10.1016/j.tube.2013.12.004. Epub 2013 Dec 31.

PMID:
24429106
9.

Shikimate kinase, a protein target for drug design.

Coracini JD, de Azevedo WF Jr.

Curr Med Chem. 2014;21(5):592-604. Review.

PMID:
24164195
10.

Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.

Vianna CP, de Azevedo WF Jr.

J Mol Model. 2012 Feb;18(2):755-64. doi: 10.1007/s00894-011-1113-5. Epub 2011 May 19.

PMID:
21594693
11.

MolDock applied to structure-based virtual screening.

De Azevedo WF Jr.

Curr Drug Targets. 2010 Mar;11(3):327-34. Review.

PMID:
20210757
12.

Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.

Segura-Cabrera A, Rodríguez-Pérez MA.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7. doi: 10.1016/j.bmcl.2008.05.003. Epub 2008 May 4.

PMID:
18486472
13.

Discovery of Helicobacter pylori shikimate kinase inhibitors: bioassay and molecular modeling.

Han C, Zhang J, Chen L, Chen K, Shen X, Jiang H.

Bioorg Med Chem. 2007 Jan 15;15(2):656-62. Epub 2006 Nov 1.

PMID:
17098431
14.

Molecular models of protein targets from Mycobacterium tuberculosis.

Silveira NJ, Uchôa HB, Pereira JH, Canduri F, Basso LA, Palma MS, Santos DS, de Azevedo WF Jr.

J Mol Model. 2005 Mar;11(2):160-6. Epub 2005 Mar 10.

PMID:
15759144

Supplemental Content

Loading ...
Support Center